
Precision therapy, targeted therapy, oncology, blood disorders, genomically defined cancers, systemic mastocytosis, lung cancer, cancer immunotherapy, rare diseases, hematology, molecular targeting, and drug design. Learn more about who we are and explore our career opportunities at. We care deeply about making a profound impact where it matters most.

Ideas come from everywhere, from the C-suite to new hires, and each day we commit to approach one another with respect and trust. Get the latest Blueprint Medicines Corp (BPMC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Our culture of transparency, curiosity, and diversity pushes us to lead with integrity, act courageously, and draw upon a wide range of backgrounds and perspectives to make decisions. We know that in order to make a difference in their lives, we must create an environment where our employees-also known as the Blue Crew-can do their best work. With patients at the center of our mission, we aim to make real the promise of precision medicine to improve and extend life for as many people with cancer and blood disorders as possible. Today, we are delivering our approved medicines directly to patients in the United States and Europe, and we are globally advancing multiple programs for systemic mastocytosis, lung cancer and other genomically defined cancers, and cancer immunotherapy. Blueprint Medicines and Krystal Biotech are two budget-friendly targets.

Since 2011, we have leveraged our research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Blueprint Medicines (BPMC) Expected to Beat Earnings Estimates: Should You Buy S&P 500 3,861.59 -56.73 (-1.45) (-1.07) 11,138.89 (-1.76) Russell 2000 1,772.70 -53.88 (-2.95) Crude Oil 76.68. Key Points AbbVie may be an active player on the merger and acquisition scene in 2023. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Blueprint Medicines is a global precision therapy company that invents life-changing medicines for people with cancer and blood disorders.
